Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Dermatologic 1

Conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia 3Sezary Syndrome 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Lymphoma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Immunoblastic Lymphadenopathy 2Waldenstrom Macroglobulinemia 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Large Granular Lymphocytic 1

Interventions

Cyclophosphamide 10Doxorubicin 6tanespimycin 5Vincristine 5Peripheral Blood Stem Cell Transplantation 5Ifosfamide 5Etoposide 5Cyclosporine 5fludarabine phosphate 4Prednisone 4Methotrexate 4Cytarabine 4Carboplatin 4Bortezomib 4Antilymphocyte Serum 4Vorinostat 3Rituximab 3Methylprednisolone 3Leucovorin 3Irinotecan 3Gemcitabine 3Filgrastim 3Dexamethasone 3Busulfan 3Brentuximab Vedotin 3Biopsy 3Bevacizumab 3merphos 2laromustine 2ixabepilone 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Lymphoma, Large-Cell, Anaplastic × nelarabine × Clear all
NCT00005080 2013-01-16

506U78 in Treating Patients With Lymphoma

National Cancer Institute (NCI)

Phase 2 Completed
74 enrolled
DermatologicLymphoidOther hematologic neoplasm

Immunoblastic Lymphadenopathy, Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡